MINNEAPOLIS (Dec. 15, 2014) – DaVita HealthCare Partners Inc. (NYSE: DVA), one of the nation’s largest and most innovative health care communities, today announced that two of its business units, DaVita Clinical Research (DCR) and HealthCare Partners Clinical Research, will merge capabilities to further expand its extensive clinical research and data analytics services, specifically in patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD), as well as primary care and chronic disease patients treated in an integrated care organization.
The merger allows the two research organizations to offer comprehensive data analytics capabilities on the longitudinal, de-identified data of approximately one million active patients receiving care at DaVita HealthCare Partners centers, including 170,000 U.S. dialysis patients receiving care from DaVita Kidney Care and 836,000 multi-specialty patients receiving coordinated, integrated care from HealthCare Partners.
“Since 1997, DaVita Clinical Research has been a leader in kidney-related trials, epidemiology and data analytics, resulting in better patient outcomes,” said Amy Young, vice president and general manager of DaVita Clinical Research. “Our clients appreciate the unique understanding of patient populations that a health care provider-based CRO like DCR can deliver.”
Biopharmaceutical and medical device developers can gain insights through access to the analytics capabilities and understanding of patient data unique to a health care provider-based clinical research organization.
“HealthCare Partners’ extensive patient database is diverse and reflects real-world evidence in an integrated care organization,” said Riya Pulicharam, MD, medical director of late phase research and clinical outcomes at HealthCare Partners Clinical Research. “We have conducted clinical trials across multiple therapeutic areas for more than 10 years, and combining our clinical research and data analytics capabilities with DCR greatly enhances our ability to meet additional clients’ needs.”
The combined entity’s capabilities – which include claims, pharmacy and electronic health record data analysis – offer strategic advantages primed to benefit recipients of its services. Including the following:
- The combined organization’s assets will help boost research-study enrollment and retention.
- The combined entity offers access to nearly a million primary care and multi-specialty patients, as well as 280,000 CKD and ESRD patients, thereby expanding the breadth and depth of the research being conducted.
- This collaboration combines – and builds on – the intellectual, financial and human resources necessary to support comprehensive analysis of scenarios ranging from burden-of-illness studies to budget impact models to market-sizing assessments.
About DaVita HealthCare Partners
DaVita HealthCare Partners Inc., a Fortune 500® company, is the parent company of DaVita Kidney Care and HealthCare Partners. DaVita Kidney Care is a leading provider of kidney care in the United States, delivering dialysis services to patients with chronic kidney failure and end stage renal disease. As of September 30, 2014, DaVita Kidney Care operated or provided administrative services at 2,152 outpatient dialysis centers located in the United States serving approximately 170,000 patients. The company also operated 87 outpatient dialysis centers located in 10 countries outside the United States. HealthCare Partners manages and operates medical groups and affiliated physician networks in Arizona, California, Nevada, New Mexico, and Florida in its pursuit to deliver excellent-quality health care in a dignified and compassionate manner. As of September 30, 2014, HealthCare Partners provided integrated care management for approximately 836,000 managed care patients. For more information, please visit DaVitaHealthCarePartners.com.
About DaVita Clinical Research
DaVita Clinical Research (DCR), a wholly owned subsidiary of DaVita HealthCare Partners Inc., uses its extensive, applied database and real-world healthcare experience to assist pharmaceutical and medical device companies in the design, recruitment, and completion of clinical trials including retrospective and prospective pragmatic trials. DCR’s scientific and clinical expertise spans the lifecycle of product development with more than 175 client companies. DCR’s Biorepository, Early Clinical Research unit (Phase I-IIa) and Late Phase Clinical Research (Phase IIb through post-marketing) network of physicians and investigative sites, data research, Health Economics & Outcomes Research,and Medical Communications are focused on providing world-class research in both healthy and chronic disease populations and therapeutic areas, and especially in CKD and ESRD populations. To learn more about DCR, visit www.davitaclinicalresearch.com.
DaVita, DaVita Clinical Research, DCR and DaVita HealthCare Partners are trademarks or registered trademarks of DaVita Healthcare Partners Inc. All other trademarks are the property of their respective owners.